交易 Jaguar Health, Inc. - JAGX CFD
新增到我的最愛- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
- 所有權
交易條件
價差 | - | ||||||||
多頭倉位隔夜費用
Long position overnight fee
前往平台 | -0.024874% | ||||||||
空頭倉位隔夜費用
Short position overnight fee
前往平台 | 0.002651% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 20% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|
Jaguar Health, Inc. Events
时间(协调世界时) (UTC) | 国家 | 事件 |
---|---|---|
No events scheduled |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
總收入 | 4.335 | 9.385 | 5.77526 | 4.41615 | 4.36119 |
收入 | 4.335 | 9.385 | 5.77526 | 4.41615 | 4.36119 |
收入成本,共計 | 2.333 | 3.28 | 3.81581 | 2.76575 | 0.88041 |
毛利 | 2.002 | 6.105 | 1.95945 | 1.6504 | 3.48078 |
總營業費用 | 45.796 | 37.896 | 39.6643 | 34.5802 | 39.0853 |
銷售/一般/行政費用,總計 | 25.997 | 20.996 | 20.4389 | 22.1088 | 14.3314 |
研究與開發 | 15.079 | 6.413 | 5.81982 | 5.15475 | 4.26946 |
異常費用(收入) | 2.387 | 7.207 | 9.58971 | 4.55093 | 19.604 |
營業收入 | -41.461 | -28.511 | -33.889 | -30.1641 | -34.7241 |
利息收入(費用),非經營淨值 | -10.374 | -5.488 | -4.72125 | -2.29767 | -0.51429 |
其他,淨值 | -0.765 | 0.19 | 0.08083 | 0.31569 | 0.08855 |
稅前淨收入 | -52.6 | -33.809 | -38.5294 | -32.1461 | -35.1499 |
稅後淨收入 | -52.6 | -33.809 | -38.5394 | -32.1461 | -21.9686 |
未計算非常項目前的淨收益 | -52.595 | -33.809 | -38.5394 | -32.1461 | -21.9686 |
淨收入 | -52.595 | -33.809 | -38.5394 | -32.1461 | -21.9686 |
Total Adjustments to Net Income | 0 | -4.839 | -6.18681 | ||
普通股股東可獲收益 (不含非經常性項目) | -52.595 | -38.648 | -44.7262 | -32.1461 | -21.9686 |
普通股股東可獲收益 (含非經常性項目) | -52.595 | -38.648 | -44.7262 | -32.1461 | -21.9686 |
攤薄淨收入 | -52.595 | -38.648 | -44.7262 | -32.1461 | -21.9686 |
攤薄後加權平均股 | 0.59601 | 0.1717 | 0.02206 | 0.00093 | 0.01287 |
扣除特別項目的每股攤薄盈利 | -88.2458 | -225.09 | -2027.26 | -34495.6 | -1707.42 |
Dividends per Share - Common Stock Primary Issue | |||||
每股正常攤薄盈利 | -84.2408 | -183.115 | -1744.73 | -29612.1 | -717.051 |
非常規項目總計 | 0 | ||||
少數股東權益 | 0.005 |
Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | |
---|---|---|---|---|---|
總收入 | 3.15 | 2.921 | 2.625 | 2.08 | 0.63 |
收入 | 3.15 | 2.921 | 2.625 | 2.08 | 0.63 |
收入成本,共計 | 0.613 | 0.456 | 0.455 | 0.469 | 0.617 |
毛利 | 2.537 | 2.465 | 2.17 | 1.611 | 0.013 |
總營業費用 | 13.046 | 9.4 | 16.566 | 12.902 | 10.159 |
銷售/一般/行政費用,總計 | 6.493 | 6.493 | 8.979 | 6.951 | 6.23 |
研究與開發 | 5.94 | 2.451 | 4.945 | 5.482 | 3.312 |
異常費用(收入) | 0 | 0 | 2.187 | 0 | 0 |
營業收入 | -9.896 | -6.479 | -13.941 | -10.822 | -9.529 |
利息收入(費用),非經營淨值 | -2.555 | -1.827 | -5.054 | -2.747 | -2.643 |
其他,淨值 | -0.158 | -1.084 | 0.831 | -0.749 | -0.02 |
稅前淨收入 | -12.609 | -9.39 | -18.164 | -14.318 | -12.192 |
稅後淨收入 | -12.609 | -9.39 | -18.164 | -14.318 | -12.192 |
未計算非常項目前的淨收益 | -12.52 | -9.367 | -17.986 | -14.313 | -12.192 |
淨收入 | -12.52 | -9.367 | -17.986 | -14.313 | -12.192 |
Total Adjustments to Net Income | 0 | 0 | |||
普通股股東可獲收益 (不含非經常性項目) | -12.52 | -9.367 | -17.986 | -14.313 | -12.192 |
普通股股東可獲收益 (含非經常性項目) | -12.52 | -9.367 | -17.986 | -14.313 | -12.192 |
攤薄淨收入 | -12.52 | -9.367 | -17.986 | -14.313 | -12.192 |
攤薄後加權平均股 | 1.41781 | 1.06239 | 0.99178 | 0.61775 | 0.61105 |
扣除特別項目的每股攤薄盈利 | -8.83053 | -8.81695 | -18.1351 | -23.1696 | -19.9525 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -8.83053 | -8.81695 | -15.9299 | -23.1696 | -19.9525 |
少數股東權益 | 0.089 | 0.023 | 0.178 | 0.005 |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
流動資産總額 | 28.434 | 17.792 | 9.52235 | 8.14994 | 3.7991 |
現金和短期投資 | 17.051 | 8.09 | 3.49543 | 2.56819 | 0.5207 |
現金等價物 | 0.5207 | ||||
應收賬款總額,淨額 | 2.144 | 4.56 | 1.69458 | 1.0018 | 0.46904 |
Accounts Receivable - Trade, Net | 1.709 | 4.532 | 1.69171 | 0.99568 | 0.46766 |
Total Inventory | 4.9 | 2.782 | 2.12869 | 3.34218 | 2.07282 |
Prepaid Expenses | 4.339 | 2.36 | 1.26274 | 1.23777 | 0.49737 |
Other Current Assets, Total | 0 | 0.94091 | 0 | 0.23917 | |
Total Assets | 53.265 | 42.843 | 36.4104 | 41.042 | 43.6292 |
Property/Plant/Equipment, Total - Net | 1.734 | 0.677 | 0.71021 | 0.76062 | 1.22207 |
Other Long Term Assets, Total | 0.446 | 0.037 | 0.15397 | 0.42083 | 0 |
Total Current Liabilities | 15.471 | 13.22 | 15.3924 | 26.6588 | 15.3858 |
Accounts Payable | 4.929 | 4.759 | 5.35154 | 5.41426 | 7.35493 |
Accrued Expenses | 7.357 | 4.493 | 3.2589 | 4.93944 | 2.19955 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 4.84558 | 1.14115 |
Current Port. of LT Debt/Capital Leases | 3.184 | 3.789 | 6.77846 | 11.2392 | 4.28146 |
Other Current Liabilities, Total | 0.001 | 0.179 | 0.00349 | 0.22038 | 0.40867 |
Total Liabilities | 41.654 | 25.641 | 15.8424 | 26.6588 | 26.3682 |
Total Long Term Debt | 25.022 | 12.421 | 0.45 | 0 | 10.9824 |
Long Term Debt | 25.022 | 12.421 | 0.45 | 0 | 10.9824 |
Other Liabilities, Total | 0.919 | 0 | |||
Total Equity | 11.611 | 17.202 | 20.568 | 14.3831 | 17.261 |
Redeemable Preferred Stock | 0 | 0 | 11.6065 | 9 | 0 |
Common Stock | 0.005 | 0.011 | 0.00546 | 0.00649 | 0.01053 |
Additional Paid-In Capital | 231.1 | 184.09 | 142.046 | 99.9274 | 79.6552 |
Retained Earnings (Accumulated Deficit) | -219.494 | -166.899 | -133.09 | -94.5508 | -62.4047 |
Total Liabilities & Shareholders’ Equity | 53.265 | 42.843 | 36.4104 | 41.042 | 43.6292 |
Total Common Shares Outstanding | 50.4733 | 40.1279 | 45.0589 | 40.4184 | 42.6378 |
Goodwill, Net | 0 | 5.21082 | |||
Intangibles, Net | 22.651 | 24.337 | 26.0239 | 31.7106 | 33.3972 |
Cash | 17.051 | 8.09 | 3.49543 | 2.56819 | |
Property/Plant/Equipment, Total - Gross | 2.032 | 0.942 | 0.93428 | ||
Accumulated Depreciation, Total | -0.298 | -0.265 | -0.22407 | ||
Total Preferred Shares Outstanding | 0 | 0 | 5.53706 | ||
Minority Interest | 0.242 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
流動資産總額 | 28.474 | 28.434 | 24.005 | 44.294 | 44.104 |
現金和短期投資 | 17.456 | 17.051 | 12.375 | 21.992 | 32.25 |
Cash | 17.456 | 17.051 | 12.375 | 21.992 | 32.25 |
應收賬款總額,淨額 | 2.255 | 2.144 | 2.205 | 4.174 | 5.927 |
Accounts Receivable - Trade, Net | 1.795 | 1.709 | 2.111 | 4.134 | 5.897 |
Total Inventory | 4.879 | 4.9 | 4.513 | 3.402 | 2.821 |
Prepaid Expenses | 3.884 | 4.339 | 4.912 | 4.806 | 3.106 |
Other Current Assets, Total | 9.92 | 0 | |||
Total Assets | 52.906 | 53.265 | 59.255 | 69.539 | 68.713 |
Property/Plant/Equipment, Total - Net | 1.757 | 1.734 | 1.7 | 1.751 | 0.674 |
Property/Plant/Equipment, Total - Gross | 2.18 | 2.032 | 1.99 | 2.033 | 0.948 |
Accumulated Depreciation, Total | -0.423 | -0.298 | -0.29 | -0.282 | -0.274 |
Intangibles, Net | 22.229 | 22.651 | 23.072 | 23.494 | 23.916 |
Other Long Term Assets, Total | 0.446 | 0.446 | 10.478 | 0 | 0.019 |
Total Current Liabilities | 19.093 | 15.471 | 11.951 | 12.652 | 12.592 |
Accounts Payable | 3.708 | 4.929 | 3.786 | 4.918 | 4.74 |
Accrued Expenses | 8.494 | 7.357 | 6.381 | 6.582 | 6.409 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 6.89 | 3.184 | 1.781 | 1.145 | 1.431 |
Other Current Liabilities, Total | 0.001 | 0.001 | 0.003 | 0.007 | 0.012 |
Total Liabilities | 44.861 | 41.654 | 37.703 | 37.754 | 36.822 |
Total Long Term Debt | 24.783 | 25.022 | 24.926 | 24.195 | 24.23 |
Long Term Debt | 24.783 | 25.022 | 24.926 | 24.195 | 24.23 |
Total Equity | 8.045 | 11.611 | 21.552 | 31.785 | 31.891 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.008 | 0.005 | 0.005 | 0.014 | 0.013 |
Additional Paid-In Capital | 245.517 | 231.1 | 226.728 | 224.76 | 210.786 |
Retained Earnings (Accumulated Deficit) | -237.48 | -219.494 | -205.181 | -192.989 | -178.908 |
Total Liabilities & Shareholders’ Equity | 52.906 | 53.265 | 59.255 | 69.539 | 68.713 |
Total Common Shares Outstanding | 79.1948 | 50.4733 | 48.2117 | 47.8944 | 44.7563 |
Total Preferred Shares Outstanding | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 0.921 | 0.919 | 0.826 | 0.907 | |
Minority Interest | 0.064 | 0.242 |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
淨收入/起跑線 | -52.6 | -33.809 | -38.5394 | -32.1461 | -21.9686 |
經營活動産生的現金 | -34.97 | -15.278 | -20.4568 | -22.7308 | -9.82494 |
經營活動産生的現金 | 1.719 | 1.727 | 1.73708 | 1.319 | 0.58434 |
非現金物品 | 13.644 | 20.271 | 17.0073 | 9.02132 | 20.6123 |
已付現金利息 | 0.028 | 0.757 | 0.142 | 0.01934 | 0.23455 |
營運資金的變化 | 2.267 | -3.467 | -0.66177 | -0.9251 | 4.12831 |
投資活動産生的現金 | -0.006 | -0.007 | 0 | -0.00653 | -1.55734 |
資本支出 | -0.006 | -0.007 | -0.00653 | 0 | |
其他投資現金流量項目,總計 | 0 | 0 | -1.55734 | ||
融資活動産生的現金 | 43.937 | 19.492 | 21.772 | 24.5457 | 10.6799 |
融資現金流項目 | -0.731 | -1.008 | -2.57481 | -2.11755 | 0 |
股票的發行(報廢),淨額 | 35.615 | 7.756 | 24.4468 | 25.8797 | 10.302 |
債務的發行(退還),淨額 | 9.053 | 12.744 | -0.1 | 0.78349 | 0.37791 |
現金淨變化 | 8.961 | 4.207 | 1.31519 | 1.80832 | -0.70241 |
Deferred Taxes | 0 | -13.1812 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -18.164 | -52.6 | -38.282 | -26.09 | -12.009 |
Cash From Operating Activities | -7.695 | -34.97 | -26.047 | -16.615 | -6.708 |
Cash From Operating Activities | 0.426 | 1.719 | 1.29 | 0.861 | 0.431 |
Non-Cash Items | 7.583 | 13.644 | 10.601 | 7.609 | 4.695 |
Cash Interest Paid | 0.011 | 0.028 | 0.021 | 0.008 | 0.006 |
Changes in Working Capital | 2.46 | 2.267 | 0.344 | 1.005 | 0.175 |
Cash From Investing Activities | -0.006 | -10.484 | -0.006 | 0 | |
Capital Expenditures | -0.006 | -0.006 | -0.006 | 0 | |
Cash From Financing Activities | 8.15 | 43.937 | 40.816 | 40.443 | 30.868 |
Financing Cash Flow Items | -0.335 | -0.731 | -0.623 | -0.268 | -0.095 |
Issuance (Retirement) of Stock, Net | 9.11 | 35.615 | 32.386 | 31.608 | 21.86 |
Issuance (Retirement) of Debt, Net | -0.625 | 9.053 | 9.053 | 9.103 | 9.103 |
Net Change in Cash | 0.405 | 8.961 | 4.285 | 23.822 | 24.16 |
Other Investing Cash Flow Items, Total | -10.478 | ||||
Foreign Exchange Effects | -0.05 |
差價合約交易計算器
如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Industry: | Bio Therapeutic Drugs |
200 Pine Street Suite 400
SAN FRANCISCO
CALIFORNIA 94104
US
收入報表
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 500.000 多名交易者,選擇與 Capital.com 交易